Cargando…
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans
BACKGROUND: Proteomics of atypical phenotypes may help unravel cardiovascular disease mechanisms. AIM: We aimed to prospectively screen the proteome of four types of individuals: with or without coronary artery disease (CAD), each with or without multiple risk factors. Associations with individual r...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855064/ https://www.ncbi.nlm.nih.gov/pubmed/35187107 http://dx.doi.org/10.3389/fcvm.2021.790289 |
_version_ | 1784653574535380992 |
---|---|
author | Ferrannini, Ele Manca, Maria Laura Ferrannini, Giulia Andreotti, Felicita Andreini, Daniele Latini, Roberto Magnoni, Marco Williams, Stephen A. Maseri, Attilio Maggioni, Aldo P. |
author_facet | Ferrannini, Ele Manca, Maria Laura Ferrannini, Giulia Andreotti, Felicita Andreini, Daniele Latini, Roberto Magnoni, Marco Williams, Stephen A. Maseri, Attilio Maggioni, Aldo P. |
author_sort | Ferrannini, Ele |
collection | PubMed |
description | BACKGROUND: Proteomics of atypical phenotypes may help unravel cardiovascular disease mechanisms. AIM: We aimed to prospectively screen the proteome of four types of individuals: with or without coronary artery disease (CAD), each with or without multiple risk factors. Associations with individual risk factors and circulating biomarkers were also tested to provide a functional context to the protein hits. MATERIALS AND METHODS: The CAPIRE study (ClinicalTrials.gov Identifier: NCT02157662) is a cross-sectional study aimed at identifying possible new mechanisms promoting or protecting against atherothrombosis. Quantification (by aptamer technology), ranking (using partial least squares), and correlations (by multivariate regression) of ~5000 plasma proteins were performed in consecutive individuals aged 45–75 years, without previous cardiovascular disease, undergoing computed tomography angiography for suspected CAD, showing either >5/16 atherosclerotic segments (CAD(+)) or completely clean arteries (CAD(−)) and either ≤ 1 risk factor (RF(+)) or ≥3 risk factors (RF(−)) (based on history, blood pressure, glycemia, lipids, and smoking). RESULTS: Of 544 individuals, 39% were atypical (93 CAD(+)/RF(−); 120 CAD(−)/RF(+)) and 61% typical (102 CAD(+)/RF(+); 229 CAD(−)/RF(−)). In the comparison with CAD(+)/RF(−) adjusted for sex and age, CAD(−)/RF(+) was associated with increased atrial myosin regulatory light chain 2 (MYO) and C-C motif chemokine-22 (C-C-22), and reduced protein shisa-3 homolog (PS-3) and platelet-activating factor acetylhydrolase (PAF-AH). Extending the analysis to the entire cohort, an additional 8 proteins were independently associated with CAD or RF; by logistic regression, the 12-protein panel alone discriminated the four groups with AUC(ROC)'s of 0.72–0.81 (overall p = 1.0e(−38)). Among them, insulin-like growth factor binding protein-3 is positively associated with RF, lower BMI, and HDL-cholesterol, renin with CAD higher glycated hemoglobin HbA(1c), and smoking. CONCLUSIONS: In a CCTA-based cohort, four proteins, involved in opposing vascular processes (healing vs. adverse remodeling), are specifically associated with low CAD burden in high CV-risk individuals (high MYO and C-C-22) and high CAD burden in low-risk subjects (high PS-3 and PAF-AH), in interaction with BMI, smoking, diabetes, HDL-cholesterol, and HbA(1c). These findings could contribute to a deeper understanding of the atherosclerotic process beyond traditional risk profile assessment and potentially constitute new treatment targets. |
format | Online Article Text |
id | pubmed-8855064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88550642022-02-19 Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans Ferrannini, Ele Manca, Maria Laura Ferrannini, Giulia Andreotti, Felicita Andreini, Daniele Latini, Roberto Magnoni, Marco Williams, Stephen A. Maseri, Attilio Maggioni, Aldo P. Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Proteomics of atypical phenotypes may help unravel cardiovascular disease mechanisms. AIM: We aimed to prospectively screen the proteome of four types of individuals: with or without coronary artery disease (CAD), each with or without multiple risk factors. Associations with individual risk factors and circulating biomarkers were also tested to provide a functional context to the protein hits. MATERIALS AND METHODS: The CAPIRE study (ClinicalTrials.gov Identifier: NCT02157662) is a cross-sectional study aimed at identifying possible new mechanisms promoting or protecting against atherothrombosis. Quantification (by aptamer technology), ranking (using partial least squares), and correlations (by multivariate regression) of ~5000 plasma proteins were performed in consecutive individuals aged 45–75 years, without previous cardiovascular disease, undergoing computed tomography angiography for suspected CAD, showing either >5/16 atherosclerotic segments (CAD(+)) or completely clean arteries (CAD(−)) and either ≤ 1 risk factor (RF(+)) or ≥3 risk factors (RF(−)) (based on history, blood pressure, glycemia, lipids, and smoking). RESULTS: Of 544 individuals, 39% were atypical (93 CAD(+)/RF(−); 120 CAD(−)/RF(+)) and 61% typical (102 CAD(+)/RF(+); 229 CAD(−)/RF(−)). In the comparison with CAD(+)/RF(−) adjusted for sex and age, CAD(−)/RF(+) was associated with increased atrial myosin regulatory light chain 2 (MYO) and C-C motif chemokine-22 (C-C-22), and reduced protein shisa-3 homolog (PS-3) and platelet-activating factor acetylhydrolase (PAF-AH). Extending the analysis to the entire cohort, an additional 8 proteins were independently associated with CAD or RF; by logistic regression, the 12-protein panel alone discriminated the four groups with AUC(ROC)'s of 0.72–0.81 (overall p = 1.0e(−38)). Among them, insulin-like growth factor binding protein-3 is positively associated with RF, lower BMI, and HDL-cholesterol, renin with CAD higher glycated hemoglobin HbA(1c), and smoking. CONCLUSIONS: In a CCTA-based cohort, four proteins, involved in opposing vascular processes (healing vs. adverse remodeling), are specifically associated with low CAD burden in high CV-risk individuals (high MYO and C-C-22) and high CAD burden in low-risk subjects (high PS-3 and PAF-AH), in interaction with BMI, smoking, diabetes, HDL-cholesterol, and HbA(1c). These findings could contribute to a deeper understanding of the atherosclerotic process beyond traditional risk profile assessment and potentially constitute new treatment targets. Frontiers Media S.A. 2022-02-04 /pmc/articles/PMC8855064/ /pubmed/35187107 http://dx.doi.org/10.3389/fcvm.2021.790289 Text en Copyright © 2022 Ferrannini, Manca, Ferrannini, Andreotti, Andreini, Latini, Magnoni, Williams, Maseri and Maggioni. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Ferrannini, Ele Manca, Maria Laura Ferrannini, Giulia Andreotti, Felicita Andreini, Daniele Latini, Roberto Magnoni, Marco Williams, Stephen A. Maseri, Attilio Maggioni, Aldo P. Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans |
title | Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans |
title_full | Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans |
title_fullStr | Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans |
title_full_unstemmed | Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans |
title_short | Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans |
title_sort | differential proteomics of cardiovascular risk and coronary artery disease in humans |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855064/ https://www.ncbi.nlm.nih.gov/pubmed/35187107 http://dx.doi.org/10.3389/fcvm.2021.790289 |
work_keys_str_mv | AT ferranniniele differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT mancamarialaura differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT ferranninigiulia differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT andreottifelicita differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT andreinidaniele differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT latiniroberto differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT magnonimarco differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT williamsstephena differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT maseriattilio differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans AT maggionialdop differentialproteomicsofcardiovascularriskandcoronaryarterydiseaseinhumans |